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This Month in the Journal
Variants in PAF-Acetylhydrolase and Asthma, by
Kruse et al. (p. 1522)
Platelet-activating factor (PAF) is a phospholipid that is
involved in inflammation. Loss-of-function mutations
in PAF hydrolase (PAFAH), an enzyme that degrades
PAF, are associated with severe asthma. In a white pop-
ulation, Kruse et al. have examined the association of
PAFAH with asthma and atopy and have found three
common variants in PAFAH: Arg92His, Ile198Thr, and
Ala379Val. Although the Arg92His variant is not as-
sociated with disease, the Ile198Thr and Ala379Val var-
iants are associated with asthmatic and atopic pheno-
types in various assays, including a measure of IgE
concentrations and a skin-prick test for specific sensiti-
zation. To understand how these variants lead to asthma
or atopy, functional studies were performed on purified
preparations of recombinant PAFAH. The Ile198Thr
and Ala379Val variants exhibit an increased KM, mean-
ing that there is a decreased substrate affinity for the
enzyme. The resulting increase in the PAF half-life pro-
longs signal transduction by this molecule and most
likely leads to higher IgE levels. The results of this study
indicate that the Ile198Thr and Ala379Val variants of
PAFAH are associated with an increased risk of asthma
and atopy and that this is probably due to decreased
enzyme efficiency.
Variants of CACNB4 in Patients with Epilepsy and
Ataxia, by Escayg et al. (p. 1531)
The voltage-gated calcium channels are involved in neu-
rotransmitter release and have been implicated in a
mouse model of epilepsy and ataxia. This model, the
lethargic mouse, has a null mutation in the b4 subunit
of these calcium channels, resulting in severe ataxia and
absence seizures. Escayg et al. have examined the human
orthologue of b4, CACNB4 on chromosome 2q22-23,
to determine whether this protein is involved in human
epilepsy and ataxia. Sequence analysis of CACNB4 in
individuals with familial epilepsy and ataxia revealed
two mutations: R482X, which shortened the protein by
38 amino acids, and C104F, a missense mutation with
incomplete penetrance. To determine the effects of these
mutations on channel activity, each was expressed in
Xenopus oocytes. Both mutations increase slightly the
current density of the channels. R482X also alters the
kinetics of channel inactivation. The effects of the mu-
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tations on channel activity, along with the cosegregation
of the mutations with disease, strongly implicate
CACNB4 as the causative mutation in these cases of
epilepsy and ataxia.
Hyperglycerolemia and Glucose Metabolism, by
Gaudet et al. (p. 1558)
Gaudet et al. have studied French Canadian families with
hyperglycerolemia, in order to determine the effects of
elevated glycerol levels on metabolism. The five families
were from a population with a known founder effect;
thus, it was possible to identify a common disease hap-
lotype on Xp21.3. This region includes the gene for glyc-
erol kinase (GK), the enzyme that brings glycerol into
the metabolic pathways. Sequence analysis of the GK
gene identified an N288D missense mutation in exon 10
of all the obligate carriers and affected individuals. In
addition to hyperglycerolemia, N288D was associated
with impaired glucose tolerance and higher body-fat ac-
cumulation, indicating that regulation of glycerol levels
has wide-reaching effects on metabolism and that the
GK gene plays an important role in this regulation. Ad-
ditional genes must be involved in this regulation, since
normoglycerolemic families, who lack mutations in
GK, also showed a correlation between mean glycerol
levels and the degree of impaired glucose tolerance.
Furthermore, the variance in plasma glycerol levels was
six times higher between than within normoglycerolemic
families.
Composite QTL Statistics, by Forrest and Feingold
(p. 1642)
Extreme discordant sibling pairs are, in theory, very
powerful for the mapping of quantitative-trait loci. In
practice, however, it is often difficult to recruit the num-
ber of discordant sib pairs that is required for this type
of mapping. Forrest and Feingold have attempted to bal-
ance these issues by developing a new statistic for the
analysis of moderately discordant sib pairs. To increase
the power of moderately discordant sib pairs, the au-
thors propose a composite statistic that uses comple-
mentary information from both an identity by descent
(IBD) statistic and a “trait value given IBD” statistic,
such as Haseman-Elston regression or variance-com-
ponents analysis. This composite statistic increases the
power of moderately discordant sib pairs in linkage anal-
ysis, it can be calculated by use of existing software, and
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it makes sample ascertainment easier than it is for ex-
tremely discordant sib pairs.
Selection at the Duffy Locus, by Hamblin and
Di Rienzo (p. 1669)
The FY*O allele of the Duffy locus is not transcribed
in red blood cells, and the lack of this cell-surface re-
ceptor gives resistance to Plasmodium vivax malaria.
FY*O has the highest known level of interpopulation
differentiation for any allele in humans. It is therefore
assumed that positive selection for the FY*O allele
through an infectious agent has led to the almost com-
plete fixation of this allele in sub-Saharan African pop-
ulations. Hamblin and Di Rienzo have studied the effects
of this selection on sequence variation in the region of
the Duffy locus. They have found that directional selec-
tion in sub-Saharan African populations has reduced the
number of polymorphic sites near the Duffy locus and
that this signature of selection extends over several kilo-
bases. In addition, they have found that the FY*O allele
occurs on two major haplotypes in three of the African
populations that they studied, and this suggests that the
FY*O allele was present in more than one haplotype
before selection occurred.
Report (Oophorectomy and the Risk for Down
Syndrome), by Freeman et al. (p. 1680)
It is well established that the risk of having a child af-
fected by Down syndrome (trisomy 21) increases with
maternal age. However, the biological basis for this risk
is not clear. As women age, there is a reduction in the
number of oocytes that they possess, and it has been
hypothesized that this leads to increased aneuploidy.
Fewer oocytes are also found in women who, because
of either surgical or congenital means, are missing all or
part of an ovary. Freeman et al. have examined the risk
of Down syndrome in this population, and this has al-
lowed them to study the effect of reduced ovarian com-
plement, independent of maternal age. They have found
that women with a reduced ovarian complement are
more likely to give birth to a child with Down syndrome.
These women are also known to show physiological
signs that are normally associated with advanced ma-
ternal age, such as lower estrogen levels and shorter men-
strual cycles. These findings suggest that the physiolog-
ical age of mothers, rather than chronological age, is
important in the assessment of the risk of Down
syndrome.
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